Dismissed (Rule 46)

No. 18-42

GlaxoSmithKline LLC v. Louisiana

from the United States Court of Appeals for the Third Circuit

See other cases from the Third Circuit.

Docket Entries

Petition Dismissed - Rule 46.

Stipulation to dismiss the petition for a writ of certiorari pursuant to Rule 46.1 filed.

Motion to extend the time to file a response is granted in part and the time is further extended to and including December 5, 2018.

Motion to extend the time to file a response from October 9, 2018 to December 10, 2018, submitted to The Clerk.

Brief amici curiae of Washington Legal Foundation, et al. filed.

Motion to extend the time to file a response is granted and the time is extended to and including October 9, 2018.

Motion to extend the time to file a response from August 8, 2018 to October 9, 2018, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due August 8, 2018)

Application (17A1096) granted by Justice Alito extending the time to file until July 6, 2018.

Application (17A1096) to extend the time to file a petition for a writ of certiorari from May 8, 2018 to July 7, 2018, submitted to Justice Alito.

Parties

GlaxoSmithKline LLC, Petitioner, represented by Lisa Schiavo Blatt

Amici Curiae

American Tort Reform Association, Amicus Curiae, represented by Cary Silverman

Pharmaceutical Research and Manufacturers of America, Amicus Curiae, represented by Paul D. Clement

The Chamber of Commerce of the United States of America, Amicus Curiae, represented by Thomas Ryan McCarthy

Washington Legal Foundation, et al., Amicus Curiae, represented by Richard A. Samp

 
Last updated: December 13, 2024